🇺🇸 Levetiracetam 250mg in United States

18 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Seizure — 4 reports (22.22%)
  2. Electrocardiogram Qt Prolonged — 2 reports (11.11%)
  3. Personality Change — 2 reports (11.11%)
  4. Product Substitution Issue — 2 reports (11.11%)
  5. Suicidal Ideation — 2 reports (11.11%)
  6. Torsade De Pointes — 2 reports (11.11%)
  7. Acute Kidney Injury — 1 report (5.56%)
  8. Agitation — 1 report (5.56%)
  9. Anger — 1 report (5.56%)
  10. Anxiety — 1 report (5.56%)

Source database →

Levetiracetam 250mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Levetiracetam 250mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Levetiracetam 250mg in United States?

Johns Hopkins University is the originator. The local marketing authorisation holder may differ — check the official source linked above.